Sotos syndrome, also known as cerebral gigantism, is an uncommon genetic disorder that manifests as an abnormal and rapid physical growth during infancy that extends until the age of three or four. This condition is often accompanied by developmental delays, necessitating ongoing assistance from therapists, counselors, and medical professionals throughout the affected individual’s life. It is important to note, however, that Sotos syndrome is not a life-threatening condition and does not necessarily recur in subsequent generations.
First Descriptions of Sotos Syndrome
In 1964, Juan F. Sotos and his colleagues published a groundbreaking study in the New England Journal of Medicine, unveiling what is now known as Sotos syndrome. This research focused on a group of children who displayed the characteristic clinical features that are now considered the defining traits of the disorder. At the time, it was commonly referred to as cerebral gigantism, as the majority of children with Sotos syndrome exhibited distinctively long and narrow facial features, as well as a significantly enlarged head circumference. It is currently estimated that Sotos syndrome affects approximately one in every 10,000 to 14,000 fetuses.
Cause: Genetic Mutation
Researchers from Japan made a significant breakthrough in 2002 when they identified a specific gene mutation, known as NSD1, as the primary cause of Sotos syndrome. It is important to note that this mutation occurs spontaneously in approximately 95 percent of cases and is not inherited from parents. Interestingly, the effects of this gene mutation can vary among individuals with Sotos syndrome in different regions. In the United States and Europe, the mutation is typically caused by small deletions of genetic material. On the other hand, in Japan, the most common genetic change associated with Sotos syndrome is a larger deletion of genetic material from a single region.